摘要7380：基于肺癌H&E图像预测免疫治疗结果

Loo等人（星期五，）研究了这个问题。

www.synapsesocial.com/papers/68e72e37b6db6435876a7fa1 — DOI: https://doi.org/10.1158/1538-7445.am2024-7380

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Abstract 2310: Integrating real-world histopathological and clinicogenomic data from 1799 lung cancer patients by applying unsupervised deep learning· 2024
2. Abstract 6189: Deep-learning model trained on multiplex immunofluorescence-stained tissue samples predicts the survival of patients with non-small cell lung cancer better than PD-L1 TPS alone· 2024
3. Abstract 4003: Path-IO: A deep learning pathomics framework for personalized immunotherapy selection and outcome prediction in metastatic non-small cell lung cancer· 2026
4. Identifying digital pathology imaging based biomarkers of checkpoint inhibitor response in non-small cell lung cancer.· 2024 · 1 citations
5. Abstract 1458: Deep learning of H&E slides adds prognostic value beyond IASLC grading in non-mucinous lung adenocarcinoma among never-smokers.· 2026